United States

Mauna Kea Technologies SAS (MKEA.PA)

MKEA.PA on Paris Stock Exchange

21 Feb 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for MKEA.PA


Mauna Kea Technologies SAS, also known as Mauna Kea Technologies SA, is a France-based company active in the healthcare business sector. It specializes in designing, developing, and selling medical imaging tools and systems. The Company’s products, used mainly in endoscopy, are intended for viewing and detecting deficiencies in... (more)


Beta: 0.75
Market Cap(Mil.): €60.15
Shares Outstanding(Mil.): 19.16
Dividend: --
Yield (%): --


  MKEA.PA Industry Sector
P/E (TTM): -- 53.53 29.68
EPS (TTM): -0.63 -- --
ROI: -64.27 7.58 13.06
ROE: -77.85 11.43 14.19

BRIEF-Mauna Kea secures a 7.0 million euros debt financing

* Mauna Kea Technologies secures a 7.0 million euros ($7.49 million) debt financing Source text for Eikon:

Feb 08 2017

BRIEF-Mauna Kea technologies appoints John Soto as chief operating officer

* Mauna Kea technologies appoints John Soto as chief operating officer

Feb 02 2017

BRIEF-Mauna Kea Technologies secures equity financing facility

* Mauna Kea Technologies secures an equity financing facility to support its development

Nov 17 2016

BRIEF-Mauna Kea Technologies gives update on cellvizio's efficacy

* Cellvizio's strong clinical efficacy in the prevention of certain pancreatic cancers confirmed by positive results from contact study presented at UEGW 2016

Oct 20 2016

BRIEF-Mauna Kea Technologies announces launch of study on cellvizio in pediatric cardiac surgery

* Announces launch of first study on cellvizio in pediatric cardiac surgery Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

Oct 12 2016

BRIEF-Mauna Kea technologies reports H1 2016 financial results

* H1 revenue 4.9 million euros ($5.47 million) versus 4.7 million euros year ago

Sep 21 2016

More From Around the Web

Earnings vs. Estimates